62 related articles for article (PubMed ID: 28650650)
1. Prodrugs of Pyrazolo[3,4-d]pyrimidines: From Library Synthesis to Evaluation as Potential Anticancer Agents in an Orthotopic Glioblastoma Model.
Vignaroli G; Iovenitti G; Zamperini C; Coniglio F; Calandro P; Molinari A; Fallacara AL; Sartucci A; Calgani A; Colecchia D; Mancini A; Festuccia C; Dreassi E; Valoti M; Musumeci F; Chiariello M; Angelucci A; Botta M; Schenone S
J Med Chem; 2017 Jul; 60(14):6305-6320. PubMed ID: 28650650
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and evaluation of a pyrazolo[3,4-d]pyrimidine derivative as a novel and potent TGFβ1R1 inhibitor.
Wang Y; Liu Y; Zhang Y; Zhang Z; Xu L; Wang J; Yang Y; Hu B; Yao Y; Wei M; Wang J; Tang B; Zhang K; Liu S; Yang G
Eur J Med Chem; 2024 May; 271():116395. PubMed ID: 38626523
[TBL] [Abstract][Full Text] [Related]
3. Functional Pyrazolo[1,5-
Arias-Gómez A; Godoy A; Portilla J
Molecules; 2021 May; 26(9):. PubMed ID: 34063043
[TBL] [Abstract][Full Text] [Related]
4. Prodrug Strategies for Paclitaxel.
Meng Z; Lv Q; Lu J; Yao H; Lv X; Jiang F; Lu A; Zhang G
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27223283
[TBL] [Abstract][Full Text] [Related]
5. Pyrazolo - Pyrimidines as Targeted Anticancer Scaffolds - A Comprehensive Review.
Kandhasamy K; Surajambika RR; Velayudham PK
Med Chem; 2024; 20(3):293-310. PubMed ID: 37885114
[TBL] [Abstract][Full Text] [Related]
6. Chemical and biological versatility of pyrazolo[3,4-
Trentini A; Hanau S; Manfrinato MC; Cacciari B
Future Med Chem; 2023 Dec; 15(23):2143-2148. PubMed ID: 37933597
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological evaluation, and pharmacokinetic study of novel liguzinediol prodrugs.
Liu Z; Li W; Wen HM; Bian HM; Zhang J; Chen L; Chen L; Yang KD
Molecules; 2013 Apr; 18(4):4561-72. PubMed ID: 23599014
[TBL] [Abstract][Full Text] [Related]
8. Light-Activatable Photocaged UNC2025 for Triggering TAM Kinase Inhibition in Bladder Cancer.
Breton-Patient C; Billotte S; Duchambon P; Fontaine G; Bombard S; Piguel S
Chembiochem; 2024 Apr; 25(8):e202300855. PubMed ID: 38363151
[TBL] [Abstract][Full Text] [Related]
9. AuNP Pyrazolo[3,4-
Molinari A; Iovenitti G; Mancini A; Gravina GL; Chebbi M; Caruana M; Vignaroli G; Orofino F; Rango E; Angelucci A; Dreassi E; Schenone S; Botta M
ACS Med Chem Lett; 2020 May; 11(5):664-670. PubMed ID: 32435368
[TBL] [Abstract][Full Text] [Related]
10. Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma Treatment.
Frumento D; Grossi G; Falesiedi M; Musumeci F; Carbone A; Schenone S
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338677
[TBL] [Abstract][Full Text] [Related]
11. Recent Advancements and Strategies for Overcoming the Blood-Brain Barrier Using Albumin-Based Drug Delivery Systems to Treat Brain Cancer, with a Focus on Glioblastoma.
Tincu Iurciuc CE; Andrițoiu CV; Popa M; Ochiuz L
Polymers (Basel); 2023 Oct; 15(19):. PubMed ID: 37836018
[TBL] [Abstract][Full Text] [Related]
12. Identification and Biological Characterization of the Pyrazolo[3,4-
Contadini C; Cirotti C; Carbone A; Norouzi M; Cianciusi A; Crespan E; Perini C; Maga G; Barilà D; Musumeci F; Schenone S
Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513870
[TBL] [Abstract][Full Text] [Related]
13. Biological Evaluation and In Vitro Characterization of ADME Profile of In-House Pyrazolo[3,4-
Poggialini F; Vagaggini C; Brai A; Pasqualini C; Crespan E; Maga G; Perini C; Cabella N; Botta L; Musumeci F; Frosini M; Schenone S; Dreassi E
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839775
[TBL] [Abstract][Full Text] [Related]
14. Autophagy Inhibition Enhances Anti-Glioblastoma Effects of Pyrazolo[3,4-
Jovanović Stojanov S; Kostić A; Ljujić M; Lupšić E; Schenone S; Pešić M; Dinić J
Life (Basel); 2022 Sep; 12(10):. PubMed ID: 36294938
[TBL] [Abstract][Full Text] [Related]
15. Anti-Survival Effect of SI306 and Its Derivatives on Human Glioblastoma Cells.
Monteleone L; Marengo B; Musumeci F; Grossi G; Carbone A; Valenti GE; Domenicotti C; Schenone S
Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890294
[TBL] [Abstract][Full Text] [Related]
16. Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy.
Upton DH; Ung C; George SM; Tsoli M; Kavallaris M; Ziegler DS
Theranostics; 2022; 12(10):4734-4752. PubMed ID: 35832071
[TBL] [Abstract][Full Text] [Related]
17. Glioblastoma: Current Status, Emerging Targets, and Recent Advances.
Thakur A; Faujdar C; Sharma R; Sharma S; Malik B; Nepali K; Liou JP
J Med Chem; 2022 Jul; 65(13):8596-8685. PubMed ID: 35786935
[TBL] [Abstract][Full Text] [Related]
18. The Pyrazolo[3,4-
Rango E; Pastorino F; Brignole C; Mancini A; Poggialini F; Di Maria S; Zamperini C; Iovenitti G; Fallacara AL; Sabetta S; Clementi L; Valoti M; Schenone S; Angelucci A; Ponzoni M; Dreassi E; Botta M
Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327462
[TBL] [Abstract][Full Text] [Related]
19. New Therapeutic Strategy for Overcoming Multidrug Resistance in Cancer Cells with Pyrazolo[3,4-
Podolski-Renić A; Dinić J; Stanković T; Tsakovska I; Pajeva I; Tuccinardi T; Botta L; Schenone S; Pešić M
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771471
[TBL] [Abstract][Full Text] [Related]
20. Pyrazolo[3,4-
Kostić A; Jovanović Stojanov S; Podolski-Renić A; Nešović M; Dragoj M; Nikolić I; Tasić G; Schenone S; Pešić M; Dinić J
Brain Sci; 2021 Jun; 11(7):. PubMed ID: 34209342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
